m6A‐dependent upregulation of DDX21 by super‐enhancer‐driven IGF2BP2 and IGF2BP3 facilitates progression of acute myeloid leukaemia
Abstract Background Acute myeloid leukaemia (AML) is a haematological malignancy with unfavourable prognosis. Despite the effectiveness of chemotherapy and targeted therapy, relapse or drug resistance remains a major threat to AML patients. N6‐methyladenosine (m6A) RNA methylation and super‐enhancer...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2024-04-01
|
| Col·lecció: | Clinical and Translational Medicine |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/ctm2.1628 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|